A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning / Rikus Knegtering en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61 Título : A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning Tipo de documento: texto impreso Autores: Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor Fecha de publicación: 2023 Artículo en la página: pp. 56-61 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone. This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU). Link: ./index.php?lvl=notice_display&id=30979 [artículo] A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning [texto impreso] / Rikus Knegtering, Autor ; Stynke Castelein, Autor ; Han Bous, Autor . - 2023 . - pp. 56-61. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 1 (Febrero) . - pp. 56-61 Palabras clave: Dibenzotiacepinas, Prolactina, Trastornos psicóticos, Fumarato de quetiapina, Risperidona, Esquizofrenia, Disfunciones sexuales, Testosterona. Resumen: To compare sexual functioning in patients treated with quetiapine or risperidone. This open-label study included patients with schizophrenia or a related psychotic illness who were randomized to quetiapine (200-1200 mg/d) or risperidone (1-6 mg/d) for 6 weeks. Sexual dysfunction was assessed by a semistructured interview, the Antipsychotics and Sexual Functioning Questionnaire (ASFQ), based upon the Utvalg for Kliniske Undersogelser (UKU). Link: ./index.php?lvl=notice_display&id=30979

Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia / Jozarni J. Dlabac de Lange en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 4 (Abril)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 411-418 Título : Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia : review and meta analysis Tipo de documento: texto impreso Autores: Jozarni J. Dlabac de Lange, Autor ; Rikus Knegtering, Autor ; André Aleman, Autor Fecha de publicación: 2022 Artículo en la página: pp. 411-418 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Terapia de modalidad combinada, Lateralidad funcional, Corteza prefrontal, Esquizofrenia, Estimulación Magnética Transcraneal. Resumen: Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a treatment for the negative symptoms of schizophrenia. During the past decade, several trials have reported on the efficacy of rTMS treatment; however, the results were inconsistent. Link: ./index.php?lvl=notice_display&id=28168 [artículo] Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia : review and meta analysis [texto impreso] / Jozarni J. Dlabac de Lange, Autor ; Rikus Knegtering, Autor ; André Aleman, Autor . - 2022 . - pp. 411-418. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 411-418 Palabras clave: Antipsicóticos, Terapia de modalidad combinada, Lateralidad funcional, Corteza prefrontal, Esquizofrenia, Estimulación Magnética Transcraneal. Resumen: Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a treatment for the negative symptoms of schizophrenia. During the past decade, several trials have reported on the efficacy of rTMS treatment; however, the results were inconsistent. Link: ./index.php?lvl=notice_display&id=28168

---

1 (1 - 2 / 2)